China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 5.64
+0.31 (5.82%)
At close: Mar 27, 2026
HKG:3320 Revenue
In the year 2025, China Resources Pharmaceutical Group had annual revenue of 269.57B CNY with 4.62% growth. China Resources Pharmaceutical Group had revenue of 137.71B in the half year ending December 31, 2025, with 12.98% growth.
Revenue
269.57B CNY
Revenue Growth
+4.62%
P/S Ratio
0.12
Revenue / Employee
3.13M CNY
Employees
86,000
Market Cap
35.43B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 269.57B | 11.90B | 4.62% |
| Dec 31, 2024 | 257.67B | 12.97B | 5.30% |
| Dec 31, 2023 | 244.70B | 26.52B | 12.16% |
| Dec 31, 2022 | 218.18B | 25.26B | 13.10% |
| Dec 31, 2021 | 192.92B | 24.16B | 14.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The United Laboratories International Holdings | 14.70B |
| Grand Pharmaceutical Group | 12.28B |
| China Medical System Holdings | 9.14B |
| Simcere Pharmaceutical Group | 8.60B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.80B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.19B |
China Resources Pharmaceutical Group News
- 1 year ago - Health product chain store CR Care to close all 19 branches in Hong Kong in November - Hong Kong Free Press